Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Drug Investigation
Published in: Clinical Drug Investigation 3/2018

01-03-2018 | Systematic Review

Lithium Toxicity in Older Adults: a Systematic Review of Case Reports

Authors: Meng Sun, Nathan Herrmann, Kenneth I. Shulman

Published in: Clinical Drug Investigation | Issue 3/2018

Login to get access

Abstract

Background and Objectives

Despite concerns regarding the vulnerability of older adults to lithium toxicity, this has not been well studied. This literature review aims to characterize the nature of lithium toxicity in older adults, the doses and serum lithium levels associated with toxicity, as well as its clinical and laboratory manifestations, precipitating factors, management and outcome.

Methods

A systematic 10-year search of English articles was conducted using Ovid Medline, Embase Classic + Embase, Cochrane Central Register of Controlled Trials and PsycINFO. All studies on lithium toxicity in elderly (aged ≥ 65 years) where the dose of lithium or serum lithium level was clearly described, were included.

Results

There were no clinical trials or cohort studies found. The search identified 38 cases of lithium toxicity in older adults with a mean age of 71.4 years (SD = 5.53). Mean dose of lithium was 675.4 mg/d (SD = 200.66), and mean toxic serum concentration was 2.55 mmol/L (SD = 2.22). Manifestations varied, with neurotoxicity being the most common, followed by renal and cardiovascular toxicity. Polypharmacy (63.2%) and medical comorbidity (76.3%) were common. Intravenous hydration and hemodialysis were widely used for treatment with good effect. Most patients recovered fully, and only one patient died despite treatment.

Conclusion

In published case reports, the lithium dose was higher than recommended for older adults. Polypharmacy and comorbidities appeared to be important precipitating factors of lithium toxicity. Regular monitoring of serum lithium concentrations and appropriate caution should be exercised, even when serum lithium concentrations are within reported therapeutic levels.
Appendix
Available only for authorised users
Literature
1.
Yatham LN, Kennedy SH, O’Donovan C, Parikh SV, MacQueen G, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord. 2006;8(6):721–39.CrossRefPubMed
2.
Alexopoulos GS, Katz IR, Reynolds CR, Carpenter D, Docherty JP. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. Postgrad Med. 2001;Spec No Pharmacotherapy:1–86.
3.
Goodwin GM, Young AH. The British Association for Psychopharmacology guidelines for treatment of bipolar disorder: a summary. J Psychopharmacol. 2003;17(4 Suppl):3–6.PubMed
4.
Shulman KI. Lithium for older adults with bipolar disorder: should it still be considered a first-line agent? Drug Aging. 2010;27(8):607–15.CrossRef
5.
Karanti A, Kardell M, Lundberg U, Landen M. Changes in mood stabilizer prescription patterns in bipolar disorder. J Affect Disord. 2016;195:50–6.CrossRefPubMed
6.
Kessing LV, Vradi E, Andersen PK. Nationwide and population-based prescription patterns in bipolar disorder. Bipolar Disord. 2016;18(2):174–82.CrossRefPubMed
7.
Al JR, Marangell LB, Petersen NJ, Martinez M, Gyulai L, Sajatovic M. Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a “recovered” status in the systematic treatment enhancement program for bipolar disorder. Am J Geriatr Psychiatry. 2008;16(11):922–33.CrossRef
8.
Shulman KI, Rochon P, Sykora K, Anderson G, Mamdani M, Bronskill S, et al. Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ. 2003;326(7396):960–1.CrossRefPubMedPubMedCentral
9.
Rej S, Beaulieu S, Segal M, Low NCP, Mucsi I, Holcroft C, et al. Lithium dosing and serum concentrations across the age spectrum: from early adulthood to the tenth decade of life. Drug Aging. 2014;31(12):911–6.CrossRef
10.
Gyulai L, Young RC. New research perspectives in the treatment of bipolar disorder in older adults. Bipolar Disord. 2008;10(6):659–61.CrossRefPubMed
11.
Hardy BG, Shulman KI, Mackenzie SE, Kutcher SP, Silverberg JD. Pharmacokinetics of lithium in the elderly. J Clin Psychopharmacol. 1987;7(3):153–8.CrossRefPubMed
12.
Young RC. Evidence-based pharmacological treatment of geriatric bipolar disorder. Psychiatr Clin North Am. 2005;28(4):837–69.CrossRefPubMed
13.
Juurlink DN, Mamdani MM, Kopp A, Rochon PA, Shulman KI, Redelmeier DA. Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc. 2004;52(5):794–8.CrossRefPubMed
14.
15.
Baird-Gunning J, Lea-Henry T, Hoegberg LC, Gosselin S, Roberts DM. Lithium poisoning. J Intensive Care Med. 2016;32:249–263.
16.
Bisogni V, Rossitto GF, Padrini R, Rossi GP. Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders. J Hypertens. 2016;34(1):20.CrossRefPubMed
17.
Gerlach L, Nakhleh R. A case of urinoma: an unusual presentation of prolonged delirium and lithium toxicity. J Am Geriatr Soc. 2016;64:S93.CrossRef
18.
Pati V, Gupta R, Verma R, Balhara YP. Neuroleptic malignant syndrome associated with lithium toxicity. Oman Med J. 2016;31(4):309.CrossRef
19.
Cobb A, Messerli A, Klingeman H, Aakre C, Mohabbat AB. A rare complication of lithium toxicity. Minnesota Med. 2015;98(8):42.PubMed
20.
Demirtas L, Akbas EM, Degirmenci H, Gurel A, Duzgun E. Multisystemic side effects of an indispensable old drug: a case report of chronic lithium use (A patient with multiple side effects of lithium). Case Rep Med. 2015;2015(pagination):472015–3931.
21.
Goel S, Nasa P, Gupta A, Gupta R, Taneja S. Lithium overdose: early hemodialysis is the key! Saudi J Kidney Dis Transpl. 2015;26(1):122–4.CrossRefPubMed
22.
Laliberte V, Yu C, Rej S. Acute renal and neurotoxicity in older lithium users: how can we manage and prevent these events in patients with late-life mood disorders? J Psychiatr Neurosci. 2015;40(4):E29–30.CrossRef
23.
Nagamine T, Yonezawa H, Nakamura K, Takahashi T, Terazono T. Adam-Stokes syndrome caused by lithium intoxication. Int Med J. 2015;22(4):343–4.
24.
Tursun I, Tazegul G, Karhan O, Gunes N, Ulukal E, Atcakarlar AT, et al. Polypharmacy may be the cause of acute lithium intoxication at the second day of treatment. Folia Medica (Plovdiv). 2015;57(3–4):261–3.PubMed
25.
Arnaoudova MD. Lithium toxicity in elderly—a case report and discussion. J IMAB Annu Proc (Scientific Papers). 2014;20(4):519–22.CrossRef
26.
Basile G, Epifanio A, Mandraffino R, Trifiro G. Parkinsonism and severe hypothyroidism in an elderly patient: a case of lithium toxicity due to pharmacological interactions. J Clin Pharm Therapeut. 2014;39(4):452–4.CrossRef
27.
Bosak AR, Graeme KA. Evans. Hemodialysis treatment of monomorphic ventricular tachycardia associated with chronic lithium toxicity. J Med Toxicol. 2014;10(3):303–6.CrossRefPubMedPubMedCentral
28.
Fernandez-Torre JL, Oterino A, Marcelino-Salas K, RiescoPerez N. Creutzfeldt-jakob-like syndrome secondary to severe lithium intoxication: a detailed follow-up electroencephalographic study. Clin Neurophysiol. 2014;125(11):2315–7.CrossRefPubMed
29.
Katz RB, Packer CD. Lithium toxicity presenting as transient transcortical motor aphasia: a case report. Psychosomat J Consult Liaison Psychiatry. 2014;55(1):87–91.
30.
Kitami M, Oizumi H, Kish SJ, Furukawa Y. Takotsubo cardiomyopathy associated with lithium intoxication in bipolar disorder: a case report. J Clin Psychopharm. 2014;34(3):410–1.CrossRef
31.
Lazarczyk MJ, Giannakopoulos P. Temporal association as a prerequisite factor of valsartan-induced lithium toxicity. Bipolar Disord. 2014;16(6):662–6.CrossRefPubMed
32.
Nat AS, Nat A, Harrison J, Rane M. Lithium toxicity: multi organ dysfunction in the elderly. Am J Resp Crit Care. 2014;189:A6172
33.
Chen WY, Chen AC, Tsai SJ, Lin JJ. Reversible oro-lingual dyskinesia related to lithium intoxication. Acta Neurologica Taiwanica. 2013;22(1):32–5.PubMed
34.
De Winter S, Meersseman W, Verelst S, Willems L, Spriet I. Drug-related admissions due to interaction with an old drug, lithium. Acta Clin Belg. 2013;68(5):356–8.CrossRefPubMed
35.
Kim SW, Sunwoo MK, Hong JY, Lee JD, Lee PH. The perfusion pattern in a patient with lithium intoxication mimicking creutzfeldt-jakob disease. J Clin Psychiat. 2013;74(12):e1134–5.CrossRef
36.
Mir SA, Wani AI, Masoodi SR, Bashir MI, Ahmad N. Lithium toxicity and myxedema crisis in an elderly patient. Indian J Endocrinol Metab. 2013;17(Suppl 3):S654–6.PubMedPubMedCentral
37.
Yamaguchi H, Inoshita M, Shirakami A, Hashimoto S, Ichimiya C, Shigekiyo T. A case of severe hypothyroidism causing cardiac tamponade associated with lithium intoxication. J Cardiol Cases. 2013;8(1):e42–5.CrossRef
38.
Babinsky E, Levene RS. Multisystem atrophy made worse by lithium treatment in a hospice patient: a case report. Am J Hosp Palliat ME. 2012;29(7):570–3.CrossRef
39.
40.
Otsuka R, Rahgoshay S, Caprio TV. Case of nephrogenic diabetes inspidus due to chronic Lithium use. J Am Geriatr Soc. 2012;60:S20–1.
41.
Sabillo S, Samala RV, Ciocon JO. A stuttering discovery of lithium toxicity. J Am Med Dir Assoc. 2012;13(7):660–1.CrossRefPubMed
42.
Boeker H, Seidl A, Schopper C. Neurotoxicity related to combined treatment with lithium, antidepressants and atypical antipsychotics: a series of cases. Schweizer Archiv fur Neurologie und Psychiatrie. 2011;162(2):72–6.CrossRef
43.
Dinesh K, Talikoti AT, Rajesh S, Raghavendra BS, Somasekharam P. Lithium toxicity in a patient with hypothyroidism—a challenge to intensivists and anaesthesiologists. J Anaesthesiol Clin Pharmacol. 2011;27(1):138–9.PubMedPubMedCentral
44.
Kohen I. Permanent lithium-induced cerebellar toxicity in an elderly patient: case report and review of the literature. Clin Geriatr. 2011;19(6):26–7.
45.
Loilier M, Lelong-Boulouard V, Debruyne D, Coquerel A. Intoxication with sustained-release lithium carbonate preparations: interest of lithium ratio, a case report. Fund Clin Pharmacol. 2011;25:48.CrossRef
46.
Kayrak M, Ari H, Duman C, Gul EE, Ak A, Atalay H. Lithium intoxication causing ST segment elevation and wandering atrial rhythms in an elderly patient. Cardiol J. 2010;17(4):404–7.PubMed
47.
Kayrak M, Duman C, Gul EE, Sonmez O, Kaya Z, Ari H. A bizarre electrocardiographic pattern due to chronic lithium therapy. Ann Noninvas Electro. 2010;15(3):289–92.CrossRef
48.
Knebel RJ, Rosenlicht N, Colllins L. Lithium carbonate maintenance therapy in a hemodialysis patient with end-stage renal disease. Am J Psychiat. 2010;167(11):1409–10.CrossRefPubMed
49.
Lloyd RB, Perkins RE, Schwartz AC. Choreoathetosis in the setting of lithium toxicity. Psychosomatics. 2010;51(6):529–31.CrossRefPubMed
50.
Meertens JHJM, Jagernath DR, Eleveld DJ, Zijlstra JG, Franssen CFM. Haemodialysis followed by continuous veno-venous haemodiafiltration in lithium intoxication; a model and a case. Eur J Intern Med. 2009;20(3):e70–3.CrossRefPubMed
51.
Wilkinson A, Gavine A, Black K. Lithium toxicity presenting as delirium in an older patient. Practitioner. 2009;253(1718):28–30.PubMed
52.
53.
Waring WS. Delayed cardiotoxicity in chronic lithium poisoning: discrepancy between serum lithium concentrations and clinical status. Basic Clin Pharmacol. 2007;100(5):353–5.CrossRef
54.
Netto I, Phutane VH. Reversible lithium neurotoxicity: review of the literature. Prim Care Comp J Clin Psychiatry. 2012;14(1) (pagination):2012.
55.
Kores B, Lader MH. Irreversible lithium neurotoxicity: an overview. Clin Neuropharmacol. 1997;20(4):283–99.CrossRefPubMed
56.
Verdoux H, Bourgeois M. Irreversible neurologic sequelae caused by lithium. Encephale. 1991;17(3):221–4.PubMed
57.
Dennison U, Clarkson M, O’Mullane J, Cassidy EM. The incidence and clinical correlates of lithium toxicity: a retrospective review. Irish J Med Sci. 2011;180(3):661–5.CrossRefPubMed
58.
Piccinelli M, Homen FG. Gender differences in the epidemiology of affective disorders and schizophrenia. Geneva: WHO Division of Mental Health; 1997.
59.
Temple R, Berman M, Carlson HE, Robbins J, Wolff J. The use of lithium in Graves’ disease. Mayo Clin Proc. 1972;47(11):872–8.PubMed
60.
Chouhan A, Abhyankar A, Basu S. The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study. Nucl Med Commun. 2016;37(1):74.PubMed
61.
Sadavoy J. Psychotropic drugs and the elderly: fast facts. New York: W. W. Norton & Company Ltd; 2004.
62.
D’Souza R, Rajji TK, Mulsant BH, Pollock BG. Use of lithium in the treatment of bipolar disorder in late-life. Curr Psychiat Rep. 2011;13(6):488–92.CrossRef
63.
Hansen HE, Amdisen A. Lithium intoxication. (Report of 23 cases and review of 100 cases from the literature). Q J Med. 1978;47(186):123–44.PubMed
64.
Peng J. Case report on lithium intoxication with normal lithium blood levels. Shanghai Arch Psychiatry. 2014;26(2):103–4.PubMedPubMedCentral
65.
Megarbane B, Hanak A, Chevillard L. Lithium-related neurotoxicity despite serum concentrations in the therapeutic range: risk factors and diagnosis. Shanghai Arch Psychiatry. 2014;26(4):243–4.PubMedPubMedCentral
66.
Canan F, Kaya A, Bulur S, Albayrak ES, Ordu S, Ataoglu A. Lithium intoxication related multiple temporary ecg changes: a case report. Cases J. 2008;1(1):156.CrossRefPubMedPubMedCentral
67.
Rej S, Looper K, Segal M. The effect of serum lithium levels on renal function in geriatric outpatients: a retrospective longitudinal study. Drug Aging. 2013;30(6):409–15.CrossRef
68.
Aprahamian I, Santos FS, Dos SB, Talib L, Diniz BS, Radanovic M, et al. Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension. J Clin Psychiatry. 2014;75(7):e672–8.CrossRefPubMed
69.
Forester BP, Streeter CC, Berlow YA, Tian H, Wardrop M, Finn CT, et al. Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy study. Am J Geriatr Psychiatry. 2009;17(1):13–23.CrossRefPubMedPubMedCentral
70.
Hsu CW, Lee Y, Lee CY, Lin PY. Neurotoxicity and nephrotoxicity caused by combined use of lithium and risperidone: a case report and literature review. BMC Pharmacol Toxicol. 2016;17(1):59.CrossRefPubMedPubMedCentral
71.
Boeker H, Seidl A, Schopper C. Neurotoxicity related to combined treatment with lithium, antidepressants and atypical antipsychotics. Schweiz Arch Neurol Psychiatr. 2011;162:72–6.CrossRef
72.
El BS, Megarbane B, Poupon J, Baud FJ, Galliot-Guilley M. Lithium poisoning: is determination of the red blood cell lithium concentration useful? Clin Toxicol (Phila). 2009;47(1):8–13.CrossRef
73.
Mowry JB, Spyker DA, Cantilena LJ, Bailey JE, Ford M. 2012 annual report of the american association of poison control centers’ national poison data system (NPDS): 30th Annual Report. Clin Toxicol (Phila). 2013;51(10):949–1229.CrossRefPubMed
74.
Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3 Suppl):21–35.CrossRefPubMed
Metadata
Title
Lithium Toxicity in Older Adults: a Systematic Review of Case Reports
Authors
Meng Sun
Nathan Herrmann
Kenneth I. Shulman
Publication date
01-03-2018
Publisher
Springer International Publishing
Published in
Clinical Drug Investigation / Issue 3/2018
Print ISSN: 1173-2563
Electronic ISSN: 1179-1918
DOI
https://doi.org/10.1007/s40261-017-0598-9

Other articles of this Issue 3/2018

Clinical Drug Investigation 3/2018 Go to the issue

Original Research Article

Surveillance on The Safety and Efficacy of Ambrisentan (Volibris Tablet 2.5 mg) in Patients with Pulmonary Arterial Hypertension in Real Clinical Practice: Post-marketing Surveillance (Interim Analysis Report)

Author Correction

Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy

Original Research Article

Pharmacokinetics of Oral and Intravenous Paracetamol (Acetaminophen) When Co-Administered with Intravenous Morphine in Healthy Adult Subjects

Review Article

A Review of Switching Biologic Agents in the Treatment of Moderate-to-Severe Plaque Psoriasis

Original Research Article

Pharmacokinetics and Safety of Ingenol Disoxate Gel Administered Under Maximum-Use Conditions to Patients With Actinic Keratosis

Original Research Article

Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?